These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
363 related articles for article (PubMed ID: 17417778)
1. Genetic investigation of DNA-repair pathway genes PMS2, MLH1, MSH2, MSH6, MUTYH, OGG1 and MTH1 in sporadic colon cancer. Schafmayer C; Buch S; Egberts JH; Franke A; Brosch M; El Sharawy A; Conring M; Koschnick M; Schwiedernoch S; Katalinic A; Kremer B; Fölsch UR; Krawczak M; Fändrich F; Schreiber S; Tepel J; Hampe J Int J Cancer; 2007 Aug; 121(3):555-8. PubMed ID: 17417778 [TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC). van der Klift H; Wijnen J; Wagner A; Verkuilen P; Tops C; Otway R; Kohonen-Corish M; Vasen H; Oliani C; Barana D; Moller P; Delozier-Blanchet C; Hutter P; Foulkes W; Lynch H; Burn J; Möslein G; Fodde R Genes Chromosomes Cancer; 2005 Oct; 44(2):123-38. PubMed ID: 15942939 [TBL] [Abstract][Full Text] [Related]
3. Risk of colorectal cancer for people with a mutation in both a MUTYH and a DNA mismatch repair gene. Win AK; Reece JC; Buchanan DD; Clendenning M; Young JP; Cleary SP; Kim H; Cotterchio M; Dowty JG; MacInnis RJ; Tucker KM; Winship IM; Macrae FA; Burnett T; Le Marchand L; Casey G; Haile RW; Newcomb PA; Thibodeau SN; Lindor NM; Hopper JL; Gallinger S; Jenkins MA Fam Cancer; 2015 Dec; 14(4):575-83. PubMed ID: 26202870 [TBL] [Abstract][Full Text] [Related]
4. Differing patterns of genetic instability in mice deficient in the mismatch repair genes Pms2, Mlh1, Msh2, Msh3 and Msh6. Hegan DC; Narayanan L; Jirik FR; Edelmann W; Liskay RM; Glazer PM Carcinogenesis; 2006 Dec; 27(12):2402-8. PubMed ID: 16728433 [TBL] [Abstract][Full Text] [Related]
5. Common variants in mismatch repair genes and risk of invasive ovarian cancer. Song H; Ramus SJ; Quaye L; DiCioccio RA; Tyrer J; Lomas E; Shadforth D; Hogdall E; Hogdall C; McGuire V; Whittemore AS; Easton DF; Ponder BA; Kjaer SK; Pharoah PD; Gayther SA Carcinogenesis; 2006 Nov; 27(11):2235-42. PubMed ID: 16774946 [TBL] [Abstract][Full Text] [Related]
6. Exome sequencing in diagnostic evaluation of colorectal cancer predisposition in young patients. Tanskanen T; Gylfe AE; Katainen R; Taipale M; Renkonen-Sinisalo L; Mecklin JP; Järvinen H; Tuupanen S; Kilpivaara O; Vahteristo P; Aaltonen LA Scand J Gastroenterol; 2013 Jun; 48(6):672-8. PubMed ID: 23544471 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemistry as first-line screening for detecting colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome: a 2-antibody panel may be as predictive as a 4-antibody panel. Shia J; Tang LH; Vakiani E; Guillem JG; Stadler ZK; Soslow RA; Katabi N; Weiser MR; Paty PB; Temple LK; Nash GM; Wong WD; Offit K; Klimstra DS Am J Surg Pathol; 2009 Nov; 33(11):1639-45. PubMed ID: 19701074 [TBL] [Abstract][Full Text] [Related]
8. Polymorphisms and HNPCC: PMS2-MLH1 protein interactions diminished by single nucleotide polymorphisms. Yuan ZQ; Gottlieb B; Beitel LK; Wong N; Gordon PH; Wang Q; Puisieux A; Foulkes WD; Trifiro M Hum Mutat; 2002 Feb; 19(2):108-13. PubMed ID: 11793469 [TBL] [Abstract][Full Text] [Related]
9. Heterozygous mutations in PMS2 cause hereditary nonpolyposis colorectal carcinoma (Lynch syndrome). Hendriks YM; Jagmohan-Changur S; van der Klift HM; Morreau H; van Puijenbroek M; Tops C; van Os T; Wagner A; Ausems MG; Gomez E; Breuning MH; Bröcker-Vriends AH; Vasen HF; Wijnen JT Gastroenterology; 2006 Feb; 130(2):312-22. PubMed ID: 16472587 [TBL] [Abstract][Full Text] [Related]
10. Clinical and Molecular Characterization of Brazilian Patients Suspected to Have Lynch Syndrome. Carneiro da Silva F; Ferreira JR; Torrezan GT; Figueiredo MC; Santos ÉM; Nakagawa WT; Brianese RC; Petrolini de Oliveira L; Begnani MD; Aguiar-Junior S; Rossi BM; Ferreira Fde O; Carraro DM PLoS One; 2015; 10(10):e0139753. PubMed ID: 26437257 [TBL] [Abstract][Full Text] [Related]
11. Mutation spectrum and risk of colorectal cancer in African American families with Lynch syndrome. Guindalini RS; Win AK; Gulden C; Lindor NM; Newcomb PA; Haile RW; Raymond V; Stoffel E; Hall M; Llor X; Ukaegbu CI; Solomon I; Weitzel J; Kalady M; Blanco A; Terdiman J; Shuttlesworth GA; Lynch PM; Hampel H; Lynch HT; Jenkins MA; Olopade OI; Kupfer SS Gastroenterology; 2015 Nov; 149(6):1446-53. PubMed ID: 26248088 [TBL] [Abstract][Full Text] [Related]
12. Analysis of the oxidative damage repair genes NUDT1, OGG1, and MUTYH in patients from mismatch repair proficient HNPCC families (MSS-HNPCC). Garre P; Briceño V; Xicola RM; Doyle BJ; de la Hoya M; Sanz J; Llovet P; Pescador P; Puente J; Díaz-Rubio E; Llor X; Caldés T Clin Cancer Res; 2011 Apr; 17(7):1701-12. PubMed ID: 21355073 [TBL] [Abstract][Full Text] [Related]
13. A review of mismatch repair gene transcripts: issues for interpretation of mRNA splicing assays. Thompson BA; Martins A; Spurdle AB Clin Genet; 2015 Feb; 87(2):100-8. PubMed ID: 24989436 [TBL] [Abstract][Full Text] [Related]
14. Mutational analysis of OGG1, MYH, MTH1 in FAP, HNPCC and sporadic colorectal cancer patients: R154H OGG1 polymorphism is associated with sporadic colorectal cancer patients. Kim IJ; Ku JL; Kang HC; Park JH; Yoon KA; Shin Y; Park HW; Jang SG; Lim SK; Han SY; Shin YK; Lee MR; Jeong SY; Shin HR; Lee JS; Kim WH; Park JG Hum Genet; 2004 Nov; 115(6):498-503. PubMed ID: 15449173 [TBL] [Abstract][Full Text] [Related]
15. Nine novel pathogenic germline mutations in MLH1, MSH2, MSH6 and PMS2 in families with Lynch syndrome. Rahner N; Friedrichs N; Wehner M; Steinke V; Aretz S; Friedl W; Buettner R; Mangold E; Propping P; Walldorf C Acta Oncol; 2007; 46(6):763-9. PubMed ID: 17653898 [TBL] [Abstract][Full Text] [Related]
16. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics. Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306 [TBL] [Abstract][Full Text] [Related]
17. Are the common genetic variants associated with colorectal cancer risk for DNA mismatch repair gene mutation carriers? Win AK; Hopper JL; Buchanan DD; Young JP; Tenesa A; Dowty JG; Giles GG; Goldblatt J; Winship I; Boussioutas A; Young GP; Parry S; Baron JA; Duggan D; Gallinger S; Newcomb PA; Haile RW; Le Marchand L; Lindor NM; Jenkins MA Eur J Cancer; 2013 May; 49(7):1578-87. PubMed ID: 23434150 [TBL] [Abstract][Full Text] [Related]
18. Genomic rearrangements in MSH2, MLH1 or MSH6 are rare in HNPCC patients carrying point mutations. Pistorius S; Görgens H; Plaschke J; Hoehl R; Krüger S; Engel C; Saeger HD; Schackert HK Cancer Lett; 2007 Apr; 248(1):89-95. PubMed ID: 16837128 [TBL] [Abstract][Full Text] [Related]
19. Contributions by MutL homologues Mlh3 and Pms2 to DNA mismatch repair and tumor suppression in the mouse. Chen PC; Dudley S; Hagen W; Dizon D; Paxton L; Reichow D; Yoon SR; Yang K; Arnheim N; Liskay RM; Lipkin SM Cancer Res; 2005 Oct; 65(19):8662-70. PubMed ID: 16204034 [TBL] [Abstract][Full Text] [Related]
20. Isolated loss of PMS2 expression in colorectal cancers: frequency, patient age, and familial aggregation. Gill S; Lindor NM; Burgart LJ; Smalley R; Leontovich O; French AJ; Goldberg RM; Sargent DJ; Jass JR; Hopper JL; Jenkins MA; Young J; Barker MA; Walsh MD; Ruszkiewicz AR; Thibodeau SN Clin Cancer Res; 2005 Sep; 11(18):6466-71. PubMed ID: 16166421 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]